Evidence map›Paper›PMID 27190539›Full record

ArticleEvidence-based complementary and alternative medicine : eCAM2016

The Relieving Effects of BrainPower Advanced, a Dietary Supplement, in Older Adults with Subjective Memory Complaints: A Randomized, Double-Blind, Placebo-Controlled Trial.

Jingfen Zhu, Rong Shi, Su Chen, Lihua Dai, Tian Shen, Yi Feng, Pingping Gu, Mina Shariff, Tuong Nguyen, Yeats Ye and 2 more

Open access · hybridAbstract read
In one paragraph

Article in Evidence-based complementary and alternative medicine : eCAM, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 2 pooled it
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 2 syntheses or guidelines pooled it, 9 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Efficacy and Safety ofNutrients · 2024
    Trial
  4. Trial
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 8 institutions in 2 countries.

Jingfen ZhuDepartment of Community Health and Family Medicine, School of Public Health, Shanghai Jiao Tong University, Shanghai 200025, China.
Rong ShiSchool of Public Health, Shanghai University of TCM, Shanghai 201203, China.
Su ChenSi-Tang Community Health Service Center of Shanghai, Shanghai 200431, China.
Lihua DaiDepartment of Emergency Medicine, Xin Hua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200092, China.
Tian ShenDepartment of Community Health and Family Medicine, School of Public Health, Shanghai Jiao Tong University, Shanghai 200025, China.
Yi FengDepartment of Community Health and Family Medicine, School of Public Health, Shanghai Jiao Tong University, Shanghai 200025, China.
Pingping GuSouthern California Kaiser Sunset, 4867 Sunset Boulevard, Los Angeles, CA 90027, USA.
Mina ShariffDepartment of Research, DRM Resources, 1683 Sunflower Avenue, Costa Mesa, CA 92626, USA.
Tuong NguyenDepartment of Research, DRM Resources, 1683 Sunflower Avenue, Costa Mesa, CA 92626, USA.
Yeats YeMaryland Population Research Center, University of Maryland, College Park, MD 20742, USA.
Jianyu RaoDepartment of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA 90095, USA.
Guoqiang XingImaging Institute of Rehabilitation and Development of Brain Function, North Sichuan Medical University, Nanchong Central Hospital, Nanchong 637000, China; Lotus Biotech.com LLC, John Hopkins University-MCC, 9601 Medical Center Drive, Rockville, MD 20850, USA.
Shanghai Jiao Tong University · CNOrange Coast College · USCommunity Health Center · USNanchong Central Hospital · CNShanghai University · CNSunset Laboratory (United States) · USUniversity of California, Los Angeles · USUniversity of Maryland, College Park · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Subjective memory complaints (SMCs) are common in older adults that can often predict further cognitive impairment. No proven effective agents are available for SMCs. The effect of BrainPower Advanced, a dietary supplement consisting of herbal extracts, nutrients, and vitamins, was evaluated in 98 volunteers with SMCs, averaging 67 years of age (47-88), in a randomized, double-blind, placebo-controlled trial. Subjective hypomnesis/memory loss (SML) and attention/concentration deficits (SAD) were evaluated before and after 12-week supplementation of BrainPower Advanced capsules (n = 47) or placebo (n = 51), using a 5-point memory questionnaire (1 = no/slight, 5 = severe). Objective memory function was evaluated using 3 subtests of visual/audio memory, abstraction, and memory recall that gave a combined total score. The BrainPower Advanced group had more cases of severe SML (severity ⩾ 3) (44/47) and severe SAD (43/47) than the placebo group (39/51 and 37/51, < 0.05, < 0.05, resp.) before the treatment. BrainPower Advanced intervention, however, improved a greater proportion of the severe SML (29.5%)(13/44) (P < 0.01) and SAD (34.9%)(15/43)(P < 0.01) than placebo (5.1% (2/39) and 13.5% (5/37), resp.). Thus, 3-month BrainPower Advanced supplementation appears to be beneficial to older adults with SMCs.

Identifiers

PMID27190539
PMCPMC4842387
OpenAlexW2313850496

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.